Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Aromatase inhibitors (AIs) have been associated with cardiovascular disease in adjuvant randomized controlled trials (RCTs) comparing these drugs to tamoxifen. However, it is unclear whether this risk is real or due to cardioprotective effects of tamoxifen. To address this question, we c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ann Oncol
Hoofdauteurs: Khosrow-Khavar, F., Filion, K. B., Al-Qurashi, S., Torabi, N., Bouganim, N., Suissa, S., Azoulay, L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2017
Onderwerpen:
Reviews
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834146/
https://ncbi.nlm.nih.gov/pubmed/27998966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw673
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items